期刊文献+

Real-time PCR方法检测高脂饲喂小鼠肝脏CYP2A5的表达

Real-time fluorescence quantitative PCR assay for detection of high-fat feeding murine liver tissue CYP2A5 expression
下载PDF
导出
摘要 为了建立非酒精性脂肪肝(NAFLD)模型小鼠肝组织中CYP2A5表达的实时荧光定量PCR(real-time fluorescence quantitative PCR,qRT-PCR)方法。高脂饮食诱导小鼠至8周,采用qRT-PCR方法检测小鼠肝脏中CYP2A5的表达水平,同时评价该方法的特异性。建立了小鼠肝组织中CYP2A5的SYBR Green实时荧光定量PCR检测方法,结果显示,该方法的溶解曲线为单峰,同时核酸电泳显示一条特异性条带。检测结果表明,高脂诱导的NAFLD小鼠肝组织中CYP2A5的表达水平极明显高于正常对照组(P<0.01)。表明该实时荧光定量PCR方法,特异性好、灵敏度强,为进一步研究小鼠CYP2A5的表达提供了试验基础。 In order to establish real-time fluorescence quantitative PCR method for detection liver CYP2A5 expression of nonalcoholic fatty liver disease (NAFLD)mouse model of NAFLD was induced with high fat diet for eight weeks. The relative expression level of mouse CYP2A5 in liver tissue was detected by qRT-PCR. The sensitivity and specificity of this method were evaluatd. The real-time fluorescence quantitative PCR method for detection liver CYP2A5 expression of NAFLD was established. The melting curve showed single peak and the amplified products were electrophoresed and a single product was observed. Compared to the control mice, the CYP2A5 relative expression was significantly increased in NAFLD mice liver tissue (P〈0.01). Thus a standard method of qRT-PCR can be used for the detection of mouse CYP2A5 expression due to its good specificity and sensitivity.
出处 《中国兽医杂志》 CAS 北大核心 2015年第12期3-5,9,共4页 Chinese Journal of Veterinary Medicine
基金 国家自然科学基金(31172369)
关键词 CYP2A5 实时荧光定量PCR NAFLD CYP2A5 real-time fluorescence quantitative PCR NAFLD
  • 相关文献

参考文献10

  • 1李娟,叶菲.非酒精性脂肪性肝病发病机制的研究进展[J].国际药学研究杂志,2011,38(5):341-344. 被引量:17
  • 2Zhou X, Zhuo X L, Xie F, et al. Role of CYP2A5 in the Clear- ance of Nicotine and Cotinine: Insights from Studies on a CYP2A5-null Mouse Model [J]. Journal of Pharmacology and Ex- perimental Therapeutics, 2010,332 : 578-587.
  • 3李晓冲,张秀英,徐尚,李宏,张燕华.C57BL/6J小鼠非酒精性脂肪肝模型的建立[J].中国兽医杂志,2013,49(1):6-8. 被引量:12
  • 4倪阵,闻勤生,赵曙光,张哲,王旭霞,王景杰,刘震雄.Nrf2基因敲除对肝脏氧化应激及胰岛素抵抗的影响[J].山西医科大学学报,2013,44(3):169-173. 被引量:5
  • 5Gilmore W J, Hartmann G, Piquette-Miller M. Effects of lipopoly- saccharide-stimulated inflammation and pyrazole-mediated hepa- tocellular injury on mouse hepatic CYP2A5 expression[J]. Toxicol- ogy, 2003 ( 184 ) : 211-226.
  • 6Correia M A, Sinclair P R, De Matteis F. Cytochrome P450 regu- lation : the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal[J] . Drug Metab Rev, 2011,43( 1 ) : 1-26.
  • 7Lamsa V, Levonen A L, Leinonen H, et al. Cytochrome P4502A5 Constitutive Expression and Induction by Heavy Metals Is Depen- dent on Redox-Sensitive Transcription Factor Nrf2 in Liver [J]. Chem Res Toxicol, 2010,23 ( 5 ) : 977-985.
  • 8Nichols K D, Kirby G M. Microarray analysis of hepatic gene ex- pression in pyrazole-mediated hepatotoxicity: Identification of po- tential stimuli of Cyp2a5 induction[J]. Biochem Pharmacol, 2008, 75(2) : 538-551.
  • 9Horowitz M P, Greenamyre J T. Mitochondrial iron metabolism and its role in neurodegeneration[J]. J Alzheimers Dis, 2010, 20 Suppl 2 : $551-$568.
  • 10曹玉珍,张秀英.高脂饲料诱发C57BL/6J小鼠非酒精性脂肪肝相关指标的动态观察[J].东北农业大学学报,2011,42(3):98-104. 被引量:3

二级参考文献39

  • 1Yu-Tao Zhan,Wei An.Roles of liver innate immune cells in nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2010,16(37):4652-4660. 被引量:35
  • 2李莉,张锦,彭阳,刘聪,李强,周一军,孟馨.代谢综合征小鼠肝脏改变及肝脏清道夫受体B1的表达[J].中国老年学杂志,2004,24(12):1168-1171. 被引量:4
  • 3Fan J G, Saibara T, Chitturi S, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific[J]. Gastroenterol Hepatol, 2007, 22: 794-800.
  • 4Liz, Soloski M J, Diehl A M. Dietary factors alter hepatic innate immune system in mice with non-alcoholic fatty liver disease[J]. Hepatology, 2005, 42(1): 880-885.
  • 5Browning JD,Szczepaniak LS,Dobbins R,et al.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology,2004,40(6):1387-1395.
  • 6Bedogni G,Miglioli L,Masutti F,et al.Prevalence of and risk factors for nonalcoholic fatty liver disease:the Dionysos nutrition and liver study[J].Hepatology,2005,42(1):44-52.
  • 7Kirovski G,Schacherer D,Wobser H,et al.Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric,biochemical and sonographic characteristics[J].Int J Clin Exp Med,2010,3(3):202-210.
  • 8Maher JJ,Leon P,Ryan JC.Beyond insulin resistance:innate immunity in nonalcoholic steatohepatitis[J].Hepatology,2008,48(2):670-678.
  • 9Baffy G.Kupffer cells in non-alcoholic fatty liver disease:the emerging view[J].J Hepatol,2009,51 (1):212-223.
  • 10Dowman JK,Tomlinson JW,Newsome PN.Pathogenesis of non-alcoholic fatty liver disease[J].QJM,2009,103 (2):71-83.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部